Results 201 to 210 of about 689,537 (284)

Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure

open access: yesCell Proliferation, EarlyView.
This article elaborates on the role of NK cells in early pregnancy from multiple perspectives, including molecular mechanisms and therapeutic interventions. It also discusses how NK cell dysfunction contributes to RSA and RIF, aiming to provide insights for future research on NK cell mechanisms and clinical treatment of RSA and RIF.
Defeng Guan   +5 more
wiley   +1 more source

Trends and outcomes of chemotherapy timing in critically ill patients with hematologic malignancies using a Japanese national database. [PDF]

open access: yesSci Rep
Iwasaki Y   +8 more
europepmc   +1 more source

A Case‐Driven Multi‐Omics Analysis for Longitudinal Ibrutinib Response Evaluation of Patients With Chronic Lymphocytic Leukemia

open access: yesEuropean Journal of Haematology, Volume 114, Issue 6, Page 973-981, June 2025.
ABSTRACT Patients with chronic lymphocytic leukemia (CLL) undergoing ibrutinib treatment often experience incomplete response, yet the molecular level underlying clonal inertia remains to be explored. We investigated the molecular and clinical dynamics of CLL during 16 months of ibrutinib monotherapy by analyzing blood samples from two patients who ...
Sólja Remisdóttir Veyhe   +9 more
wiley   +1 more source

Erythematous Macular Eruption in an Older Woman [PDF]

open access: yes, 2019
Kernohan, Neil   +2 more
core   +2 more sources

Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies

open access: yesEuropean Journal of Haematology, Volume 114, Issue 6, Page 938-952, June 2025.
ABSTRACT The treatment landscape for relapsed or refractory acute lymphoblastic leukemia (RR ALL) has evolved significantly with the introduction of monoclonal antibodies such as blinatumomab and inotuzumab ozogamicin. These agents have demonstrated remarkable efficacy, achieving high response rates and minimal residual disease (MRD) negativity ...
Antonella Bruzzese   +11 more
wiley   +1 more source

Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2012
C. Carmichael   +7 more
semanticscholar   +1 more source

Dual Targeting of Pim and PI3 Kinases in Mature T‐Cell Lymphoma

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Provirus Integration site for Moloney leukemia virus (Pim) family members are well‐known oncogenes, with an expression that is restricted to few cell types including hematopoietic cells in adult organisms, making it a promising target for lymphoma treatment.
M. Lohrberg   +13 more
wiley   +1 more source

Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesis. [PDF]

open access: yesAnn Hematol
Iberti M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy